Celebrating 20 years
Brain imaging abnormalities and outcome after acute ischaemic stroke: the ENCHANTED trial
Building back better after COVID-19: The research agenda
The wider benefits of SGLT2 inhibitors
Results from the Auckland Regional Community Stroke Study (ARCOS) - a stroke incidence and outcome study conducted in 2002-2003 - have been used to inform government policy and healthcare planning in New Zealand and Australia.